Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease

BACKGROUND: Pregnant women with inflammatory bowel disease (IBD) may require biologic or thiopurine therapy to control disease activity. Lack of safety data has led to therapy discontinuation during pregnancy with health repercussions to mother and child. METHODS: Between 2007 and 2019, pregnant wom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterology
Main Authors: Mahadevan, Uma, Long, Millie D., Kane, Sunanda V., Roy, Abhik, Dubinsky, Marla C., Sands, Bruce E., Cohen, Russell D., Chambers, Christina D., Sandborn, William J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956164/
https://ncbi.nlm.nih.gov/pubmed/33227283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2020.11.038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados